Mather Group’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-3
Closed -$64 2010
2024
Q2
$64 Buy
+3
New +$64 ﹤0.01% 2154